Recce Pharmaceuticals Ltd
ASX:RCE
Recce Pharmaceuticals Ltd
ASX:RCE
Price:
0.61
AUD
5.17%
Market Closed
Market Cap:
AU$176.4m
Relative Value
The Relative Value of one
RCE
stock under the Base Case scenario is
hidden
AUD.
Compared to the current market price of 0.61 AUD,
Recce Pharmaceuticals Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
RCE Relative Value
HIDDEN
Multiples Across Competitors
RCE Competitors Multiples
Recce Pharmaceuticals Ltd Competitors
Recce Pharmaceuticals Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
|
Recce Pharmaceuticals Ltd
ASX:RCE
|
175.9m AUD | 22.8 | -8.2 | -8.6 | -8.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
972.6B USD | 14.9 | 46.9 | 31.6 | 33.7 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
575B USD | 6.1 | 21.5 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
281.9B CHF | 4.6 | 29.9 | 12.6 | 14.8 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
226.9B GBP | 5.4 | 33.6 | 16 | 23.4 | |
| CH |
|
Novartis AG
SIX:NOVN
|
235.6B CHF | 5.4 | 21.7 | 13.4 | 17.2 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
291.8B USD | 4.5 | 16.1 | 10.1 | 11.8 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.4 | 13.2 | 9.7 | 11.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
155.9B USD | 2.5 | 20.3 | 7.5 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122.8B USD | 2.6 | 17.5 | 6.8 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
